数位生物标记市场规模、份额及成长分析（按类型、临床实践、治疗领域、最终用户和地区）—2025-2032 年产业预测

2023 年全球数位生物标记市场规模价值 39 亿美元，预计将从 2024 年的 50.2 亿美元成长到 2032 年的 380.5 亿美元，预测期内（2025-2032 年）的复合年增长率为 28.8%。

由于医疗技术的快速进步、医疗成本的上升以及对远距护理服务和远端患者监护的需求不断增加，数位生物标记市场正在经历强劲增长。推动这一市场的关键因素包括对分散临床试验的投资增加、治疗应用数量的增加以及可穿戴设备的普及和智慧型手机的广泛普及。能够检测呼吸、声音、温度和眼球运动等重要指标的创新技术可以实现对复杂疾病的即时监测。值得注意的是，语音数位生物标记物具有巨大的成长机会。卢森堡健康研究所的 CoLive Voice 等措施凸显了远距风险评估和疾病管理的潜力。随着越来越多的消费者采用智慧型手錶和健身追踪器，市场有望继续扩张。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 宏观经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术分析

数位生物标誌物市场规模（按类型）

• 市场概览
• 穿戴式装置
• 基于行动的应用程式
• 感应器
• 其他的

按临床实践分類的数位生物标记市场规模

• 市场概览
• 诊断数位生物标记
• 监测数位生物标记
• 预测和预后数位生物标记物
• 其他的

按治疗领域分類的数位生物标记市场规模

• 市场概览
• 心血管和代谢疾病（CVMD）
• 呼吸系统疾病
• 精神障碍
• 睡眠和运动障碍
• 神经系统疾病
• 肌肉骨骼疾病
• 其他的

按最终用户分類的数位生物标记市场规模

• 市场概览
• 医疗保健公司
• 医疗保健提供者
• 付款人
• 其他的

数位生物标记市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• BioSensics（United States）
• AliveCor（United States）
• BACtrack（United States）
• Eyenuk（United States）
• Quibim（Spain）
• Biofourmis（United States）
• Fitbit（United States）
• Evidation Health（United States）
• Empatica（United States）
• Philips Healthcare（Netherlands）
• Medtronic（Ireland）
• Akili Interactive（United States）
• Apple Inc.（United States）
• Biotricity（United States）
• Tempus（United States）
• Pear Therapeutics（United States）
• BioBeats（United Kingdom）
• Oura Health（Finland）
• ActiGraph（United States）
• Koneksa（United States）

结论和建议

Global Digital Biomarkers Market size was valued at USD 3.9 billion in 2023 and is poised to grow from USD 5.02 billion in 2024 to USD 38.05 billion by 2032, growing at a CAGR of 28.8% during the forecast period (2025-2032).

The digital biomarkers market is experiencing robust growth, driven by rising demand for telecare services and remote patient monitoring, alongside rapid advancements in healthcare technology and increased healthcare expenditure. Key factors propelling this market include growing investments in decentralized clinical trials, expanding therapeutic applications, and the surge in wearable devices amid widespread smartphone usage. Innovative technologies capable of detecting vital indicators such as breathing, voice, heat, and eye movements are enabling real-time monitoring of complex diseases. Notably, vocal digital biomarkers present significant growth opportunities. Initiatives like the CoLive Voice by the Luxembourg Institute of Health highlight the potential for remote risk assessment and disease management. With an increasing number of consumers utilizing smartwatches and fitness trackers, the market is poised for continued expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Biomarkers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Biomarkers Market Segments Analysis

Global Digital Biomarkers Market is segmented by Type, Clinical Practice, Therapeutic Area, End Users and region. Based on Type, the market is segmented into Wearable, Mobile based Applications, Sensors and Others. Based on Clinical Practice, the market is segmented into Diagnostic digital biomarkers, Monitoring digital biomarkers, Predictive and Prognostic digital biomarkers and Others. Based on Therapeutic Area, the market is segmented into Cardiovascular and metabolic disorders (CVMD), Respiratory disorders, Psychiatric disorders, Sleep & Movement Disease, Neurological disorders, Musculoskeletal disorders and Others. Based on End Users, the market is segmented into Healthcare companies, Healthcare Providers, Payers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Digital Biomarkers Market

The rise in the prevalence of diabetes, hypertension, and cardiovascular diseases is driving the demand for digital biomarkers. These advanced health indicators provide essential insights that enable healthcare systems to respond promptly and maintain continuous monitoring of chronic conditions. By facilitating optimal management practices, digital biomarkers empower patients to maintain their health for extended periods and minimize hospital visits. This proactive approach not only enhances patients' quality of life but also helps reduce overall healthcare costs. Consequently, the increasing focus on managing chronic illnesses is significantly fueling the global market for digital biomarkers, highlighting their importance in modern healthcare.

Restraints in the Global Digital Biomarkers Market

While digital biomarkers show significant potential, a major challenge lies in their lack of clinical validation, which is essential for their widespread acceptance among medical professionals. Due to insufficient rigorous research to establish their effectiveness in real-world applications, concerns regarding their accuracy and reliability are prevalent. This gap in validation hinders the broader acceptance and integration of digital biomarkers into standard treatment protocols, as healthcare providers prefer to utilize evidence-based tools that have proven efficacy. Consequently, the limited clinical validation of these biomarkers may impede their ability to gain traction in routine medical practice, posing a significant restraint in the global digital biomarkers market.

Market Trends of the Global Digital Biomarkers Market

The Global Digital Biomarkers market is witnessing a significant trend towards the integration of artificial intelligence (AI), which enhances the capability of wearables and health applications to generate data. By employing advanced AI algorithms to analyze and interpret this data, healthcare providers can uncover patterns and insights that might not be readily apparent, leading to more proactive and individualized healthcare approaches. This trend is pivotal in improving illness management and optimizing patient outcomes, as it amplifies the predictive power of digital biomarkers. Consequently, the market is positioned for robust growth, driven by the increasing reliance on technology for personal health monitoring and disease management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Digital Biomarkers Market Size by Type & CAGR (2025-2032)

• Market Overview
• Wearable
• Mobile based Applications
• Sensors
• Others

Global Digital Biomarkers Market Size by Clinical Practice & CAGR (2025-2032)

• Market Overview
• Diagnostic digital biomarkers
• Monitoring digital biomarkers
• Predictive and Prognostic digital biomarkers
• Others

Global Digital Biomarkers Market Size by Therapeutic Area & CAGR (2025-2032)

• Market Overview
• Cardiovascular and metabolic disorders (CVMD)
• Respiratory disorders
• Psychiatric disorders
• Sleep & Movement Disease
• Neurological disorders
• Musculoskeletal disorders
• Others

Global Digital Biomarkers Market Size by End Users & CAGR (2025-2032)

• Market Overview
• Healthcare companies
• Healthcare Providers
• Payers
• Others

Global Digital Biomarkers Market Size & CAGR (2025-2032)

• North America (Type, Clinical Practice, Therapeutic Area, End Users)
  • US
  • Canada
• Europe (Type, Clinical Practice, Therapeutic Area, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Clinical Practice, Therapeutic Area, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Clinical Practice, Therapeutic Area, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Clinical Practice, Therapeutic Area, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• BioSensics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AliveCor (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BACtrack (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eyenuk (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quibim (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biofourmis (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fitbit (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evidation Health (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Empatica (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akili Interactive (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apple Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotricity (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tempus (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pear Therapeutics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioBeats (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oura Health (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ActiGraph (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koneksa (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations